JP Morgan Chase
RCKT icon

JP Morgan Chase’s Rocket Pharmaceuticals RCKT Stock Holding History

JP Morgan Chase’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-354,700
Closed -$9.56M – 7686
2024
Q1 		$9.56M Buy
354,700
+171,300
+93% +$4.87M ﹤0.01% 2534
2023
Q4 		$5.5M Buy
+183,400
New +$4.05M ﹤0.01% 2992
2023
Q3 		– Sell
-43,400
Closed -$862K – 7684
2023
Q2 		$862K Buy
+43,400
New +$877K ﹤0.01% 4171

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

JP Morgan Chase's RCKT Position: Q2 2026 in Review

JP Morgan Chase increased its Rocket Pharmaceuticals (RCKT) stake by 150% in Q2 2026, buying an estimated $3.96M and bringing the position to 1,988,413 shares worth $6.7M. The position accounts for ﹤0.01% of the portfolio, ranked #3176.

JP Morgan Chase first reported a position in RCKT in Q1 2016 and has held it in 38 quarters since. The position peaked at $35M in Q2 2021. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • JP Morgan Chase held 1,988,413 shares of Rocket Pharmaceuticals worth $6.7M as of Q2 2026.
  • JP Morgan Chase bought 1,192,189 Rocket Pharmaceuticals shares in Q2 2026, an estimated $3.96M.
  • Rocket Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3176 holding.
  • JP Morgan Chase first reported a position in Rocket Pharmaceuticals in Q1 2016 and has held it in 38 quarters since.
  • JP Morgan Chase's Rocket Pharmaceuticals position peaked at $35M in Q2 2021.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.